Miami, Florida– The International Society for Stem Cell Application (ISSCA), a distinguished division of the Global Stem Cells Group (GSCG), is thrilled to announce a series of upcoming events in 2024 dedicated to advancing the field of regenerative medicine.
With over 15 years of leadership in regenerative medicine, ISSCA has been a pioneer in non-profit education, dedicated to allowing physicians to present the benefits of stem cell medicine to patients worldwide and establishing itself as a global leader in certification, education, research, and training in regenerative medicine.
Mastering the Next Generation of Regenerative Medicine and Cellular Therapy
The “Leading the Charge: Mastering Next-Generation Cellular Therapies” course is scheduled for October 4-5. This course is designed to provide participants with a deep understanding of the most advanced cellular therapies. The course focuses on natural killer cells (NK), cutting-edge Cellgenic cellular products, and therapeutic peptides, along with practical techniques for effective application of these therapies. This innovative course updates the latest accessible technologies for doctors and includes protocols for biohacking at the cellular level, state-of-the-art technologies, and therapeutic applications.
International Conference in Peru
On September 6-7, ISSCA will host a prestigious conference in Lima, Peru, expected to draw hundreds of physicians. This event will provide a unique platform to discuss the latest advancements in regenerative medicine and stem cell therapy. Attendees will have the opportunity to engage in presentations and workshops led by top doctors and scientists from around the world, sharing extensive knowledge and insights. The conference will also offer invaluable networking opportunities with newly established clinics, fostering collaboration and advancing medical knowledge within the region.
International Conference in Argentina
Following the Peru event, ISSCA will hold another significant conference in Buenos Aires, Argentina on October 25-26. This conference aims to continue the momentum by bringing together hundreds of physicians to discuss the most recent developments in regenerative medicine. This gathering underscores the Global Stem Cells Group’s commitment to promoting collaboration and knowledge exchange in the field of regenerative medicine in Argentina and South America.
International Conference in Dubai
The series of international conferences will culminate with an event in Dubai, UEA on November 30 – December 1. This conference is expected to attract a large number of physicians from GCC countries. It will provide an exceptional opportunity to explore the latest advancements in regenerative medicine and stem cell therapy. The event will also facilitate valuable networking opportunities, helping to establish connections and collaborations in the rapidly evolving field of regenerative medicine.
These conferences will feature a full schedule of lectures highlighting significant subjects such as molecular biology, innovative treatment approaches in surgical and cosmetic domains, and the latest cutting-edge technologies in the field. Additionally, the conferences will explore the legal framework encompassing regenerative medicine practices globally, acknowledging the varying degrees of involvement by national governments.
These events are ISSCA’s dedication to facilitating a transformative change from traditional healthcare methods to regenerative medicine. They will showcase the latest innovative discoveries and progress in all aspects of stem cell research.
About ISSCA
The International Society for Stem Cell Application (ISSCA) is a leading organization in the field of regenerative medicine. It is dedicated to advancing the science and practice of stem cell therapy and regenerative medicine through education, certification, research, and training. ISSCA provides certification training in cities worldwide, recognizing the importance of standards and certifications in regenerative medicine as a medical specialty.
ISSCA’s mission is to promote the benefits of stem cell medicine to patients globally, ensure the quality and uniformity of regenerative medicine practices, and establish itself as a global leader in the certification and education of medical professionals in this field. The organization is a distinguished division of the Global Stem Cells Group (GSCG) and has over 15 years of experience in the industry, making significant contributions to the advancement and dissemination of regenerative medicine knowledge and practices.
About Global Stem Cells Group
Global Stem Cells Group is a leading provider of regenerative medicine solutions, dedicated to advancing healthcare through innovative therapies. With a global presence and a multidisciplinary team of experts, the organization strives to harness the potential of stem cells and regenerative medicine to improve patient outcomes across various medical fields. Through its extensive network of clinics, research facilities, and training centers, Global Stem Cells Group is committed to pushing the boundaries of regenerative medicine and making a positive impact on global healthcare.
Global Stem Cells Group is a publicly traded company operating under the symbol MSSV. https://finance.yahoo.com/quote/mssv/
To learn more about Global Stem Cells Group, Inc.’s companies visit our website www.stemcellsgroup.com or call +1 305 560 5331
Safe Harbor Statement: Statements in this news release may be “forward-looking statements”. Forward-looking statements include, but are not limited to, statements that express our intentions, beliefs, expectations, strategies, predictions, or any other information relating to our future activities or other future events or conditions. These statements are based on current expectations, estimates, and projections about our business based partly on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties, and assumptions that are difficult to predict. Therefore, actual outcomes and results may and are likely to differ materially from what is expressed or forecasted in forward-looking statements due to numerous factors. Any forward-looking statements speak only as of the date of this news release, and The Global Stem Cells Group undertakes no obligation to update any forward-looking statement to reflect events or circumstances after the date of this news release. This press release does not constitute a public offer of any securities for sale. Any securities offered privately will not be or have not been registered under the Act and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.
